ESSEX INVESTMENT MANAGEMENT CO LLC - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 87 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
ESSEX INVESTMENT MANAGEMENT CO LLC ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2018$2,275,000
+14.0%
167,756
-0.3%
0.27%
+6.8%
Q2 2018$1,996,000
-52.5%
168,187
-55.0%
0.25%
-54.7%
Q1 2018$4,200,000
+620.4%
374,017
+328.4%
0.55%
+616.9%
Q4 2017$583,000
-2.5%
87,307
+19.6%
0.08%
-4.9%
Q3 2017$598,000
-30.6%
72,996
-62.0%
0.08%
-34.1%
Q2 2017$862,000
+283.1%
192,045
+371.0%
0.12%
+251.4%
Q1 2017$225,000
-54.3%
40,772
-32.7%
0.04%
-58.3%
Q1 2016$492,00060,5750.08%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q2 2018
NameSharesValueWeighting ↓
NEA Management Company, LLC 15,832,611$68,080,0003.54%
Matrix Capital Management Company, LP 28,000,000$120,400,0003.21%
Virtus ETF Advisers LLC 50,655$218,0000.46%
TFG Asset Management GP Ltd 500,000$2,150,0000.27%
Rock Springs Capital Management LP 800,000$3,440,0000.13%
Orbimed Advisors 1,350,655$5,808,0000.09%
Vident Investment Advisory, LLC 289,340$1,244,0000.07%
WS MANAGEMENT LLLP 185,537$798,0000.05%
Rathbones Group PLC 285,722$1,229,0000.04%
Tekla Capital Management LLC 228,496$983,0000.04%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders